相关实验视频

Updated: Jan 20, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

由脂质过氧化引起的4-HNE诱导的细胞功能障碍:糖尿病心肌病的潜在治疗标

Nan Jiang¹, Yanchun Ma², Huijun Chen³

¹Geriatric Psychiatry, Second People's Hospital of Zhoushan, Zhoushan, China.

Frontiers in cell and developmental biology

|January 19, 2026

概括

糖尿病心肌病症涉及由4-基-2-nonenal (4-HNE) 驱动的有机细胞功能障碍. 针对这些有机体为糖尿病心脏病提供了新的治疗策略.

科学领域:

生物化学生物化学
心脏病学心脏病学
分子生物学分子生物学

背景情况:

糖尿病心肌病 (DCM) 是糖尿病患者心力衰竭的主要原因.
目前DCM的治疗方法有限,这突显了了解其分子机制的必要性.
这种疾病的特征是腹功能障碍,心肌细胞亡和纤维化,往往会发展为心力衰竭,并保留喷射分数.

研究的目的:

为了阐明4-基-2-nonenal (4-HNE) 在DCM病变发生过程中的作用.
研究4-HNE的亚细胞点,重点研究器官相互作用.
根据4-HNE的分子机制,确定DCM的潜在治疗策略.

主要方法:

审查关于DCM,氧化应激和4-HNE的现有文献.
对4-HNE对细胞器官的影响分析,包括线粒体,内质网膜和溶解体.
综合证据将4-HNE与能量耗尽,过载,自流阻塞和铁死联系起来.

主要成果:

4-基-2-nonenal (4-HNE) 是糖尿病中脂质过氧化的产物,在DCM进展中起着至关重要的作用.
4-HNE 干扰器官功能,导致能量耗尽,过载,自功能受损和铁亡.
线粒体,内分泌网膜和溶解体之间的相互作用是4-HNE诱导的细胞损伤的核心.

结论:

准器官功能障碍为DCM提供了一个有前途的治疗方法.
潜在的疗法包括ALDH2激活剂,GPR40激动剂,针对线粒体的抗氧化剂和铁灭菌抑制剂.
对4-HNE亚细胞点的进一步研究可以指导糖尿病心脏病的临床干预.

关键词:

在 4-HNE 中,糖尿病心肌病糖尿病心肌病脂质过氧化过氧化有机器人有机器人氧化应激是一种氧化应激.

更多相关视频

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

相关概念视频

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

This protocol outlines a method for inducing diabetic cardiomyopathy through a combination of high-fat diet feeding and streptozotocin injection. This approach aims to provide a reliable framework for scientific investigation into diabetic cardiomyopathy and to explore potential avenues for clinical treatment...

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Here, we present a protocol to produce tachycardia-induced cardiomyopathy in swine. This model represents a potent way to study the hemodynamics of progressive chronic heart failure and the effects of applied...

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

We describe here a fluorometric cell-free biochemical assay for determination of HDL-lipid peroxidation. This rapid and reproducible assay can be used to determine HDL function in large scale studies and can contribute to our understanding of HDL function in human...

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

A Mouse 5/6^th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

This manuscript provides a detailed two-step surgical procedure to perform mouse 5/6th partial nephrectomy (PNx) with pole ligation. Four weeks after surgery, in comparison with sham-operated mice, the PNx mice developed impaired renal function, anemia, cardiac hypertrophy, cardiac fibrosis, and decreased heart systolic and diastolic...

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Here, we present a protocol to establish a mouse model of diabetic cardiomyopathy and a mouse electroacupuncture fixation device for the use of electroacupuncture in mice, which can fix the mice more gently during...